Your browser doesn't support javascript.
loading
Venetoclax-based low intensity therapy in molecular failure of NPM1-mutated AML.
Jimenez-Chillon, Carlos; Othman, Jad; Taussig, David; Jimenez-Vicente, Carlos; Martinez-Roca, Alexandra; Tiong, Ing Soo; Jain, Manish; Aries, James; Cakmak, Seda; Knapper, Steven; Kristensen, Daniel Tuyet; Murthy, Vidhya; Galani, Joy Zacharoula; Kallmeyer, Charlotte; Ngu, Loretta; Veale, David; Bolam, Simon; Orfali, Nina; Parker, Anne; Manson, Cara; Parker, Jane; Erblich, Thomas; Richardson, Deborah; Mokretar, Katya; Potter, Nicola; Overgaard, Ulrik Malthe; Roug, Anne Stidsholt; Wei, Andrew H; Esteve, Jordi; Jädersten, Martin; Russell, Nigel; Dillon, Richard.
Afiliação
  • Jimenez-Chillon C; Servicio de Hematología y Hemoterapia, Hospital Universitario Ramón y Cajal, Madrid, Spain.
  • Othman J; Department of Medical & Molecular Genetics, King's College London, London, United Kingdom.
  • Taussig D; Department of Medical & Molecular Genetics, King's College London, London, United Kingdom.
  • Jimenez-Vicente C; Guy's and St Thomas Hospital, London, United Kingdom.
  • Martinez-Roca A; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.
  • Tiong IS; Department of Haematology, Royal Marsden Hospital, Sutton, United Kingdom.
  • Jain M; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.
  • Aries J; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.
  • Cakmak S; Hematology Department, Hospital Clínic Barcelona, Barcelona, Spain.
  • Knapper S; Peter MacCallum Cancer Centre, Royal Melbourne Hospital and Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.
  • Kristensen DT; Alfred Hospital and Monash University, Melbourne, VIC, Australia.
  • Murthy V; Austin Health and Olivia Newton John Cancer Research Institute, Melbourne, VIC, Australia.
  • Galani JZ; Department of Haematology, Leeds Teaching Hospitals Trust, Leeds, United Kingdom.
  • Kallmeyer C; Department of Haemato-Oncology, St Bartholomew's Hospital, London, United Kingdom.
  • Ngu L; Department of Haemato-Oncology, St Bartholomew's Hospital, London, United Kingdom.
  • Veale D; Department of Haematology, School of Medicine, Cardiff University, Cardiff, United Kingdom.
  • Bolam S; Department of Haematology, Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark.
  • Orfali N; Department of Haematology, University Hospitals of Birmingham, Birmingham, United Kingdom.
  • Parker A; Department of Haematology, Dartford & Gravesham NHS Trust, Dartford, United Kingdom.
  • Manson C; Department of Haematology, Lincoln County Hospital, Lincoln, United Kingdom.
  • Parker J; Department of Haematology, Royal Devon University Healthcare NHS Foundation Trust, Exeter, United Kingdom.
  • Erblich T; Department of Haematology, Royal Devon University Healthcare NHS Foundation Trust, Exeter, United Kingdom.
  • Richardson D; Department of Haematology, Taunton and Somerset NHS Foundation Trust, Taunton, United Kingdom.
  • Mokretar K; Department of Haematology, St. James's Hospital, Dublin, Ireland.
  • Potter N; Department of Haematology, Queen Elizabeth University Hospital, Glasgow, United Kingdom.
  • Overgaard UM; Department of Haematology, Queen Elizabeth University Hospital, Glasgow, United Kingdom.
  • Roug AS; Department of Haematology, Northampton General Hospital, Northampton, United Kingdom.
  • Wei AH; Department of Haematology, The London Clinic, London, United Kingdom.
  • Esteve J; Department of Haematology, University Hospital Southampton, Southampton, United Kingdom.
  • Jädersten M; Synnovis, London, United Kingdom.
  • Russell N; Department of Medical & Molecular Genetics, King's College London, London, United Kingdom.
  • Dillon R; Department of Haematology, Rigshospitalet, Copenhagen, Denmark.
Blood Adv ; 8(2): 343-352, 2024 01 23.
Article em En | MEDLINE | ID: mdl-38039513
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Sulfonamidas / Proteínas Nucleares / Leucemia Mieloide Aguda / Compostos Bicíclicos Heterocíclicos com Pontes Limite: Humans Idioma: En Revista: Blood Adv Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Sulfonamidas / Proteínas Nucleares / Leucemia Mieloide Aguda / Compostos Bicíclicos Heterocíclicos com Pontes Limite: Humans Idioma: En Revista: Blood Adv Ano de publicação: 2024 Tipo de documento: Article